Join the 'Arco-Lase' group to help and get support from people like you.
Posted 7 May 2009 by Drugs.com
THURSDAY, May 7 – Creon (pancrelipase), a pancreatic enzyme replacement for people with cystic fibrosis and other conditions that involve exocrine pancreatic insufficiency, has been approved by the U.S. Food and Drug Administration for adults and children. The drug is designed to help people with these conditions absorb dietary nutrients, including fats, proteins and sugars. Creon is made from a mixture of digestive enzymes extracted from the pancreas of pigs, the FDA said in a news release. While the agency acknowledged a "theoretical risk of contracting a viral infection from pig-derived medicines," it said no cases of human illness stemming from the drug had been reported. The maker of Creon, Solvay Pharmaceuticals, is required to submit both a risk evaluation assessment and medication guide, designed to advise users of the risks of pig-derived drugs, and about the risk of taking ... Read more